by Terry Myerson, CEO | Nov 20, 2023 | Culture
Eight months ago, we had a fateful meeting… “We have some incredibly diverse and engaged customers doing innovative work that would benefit from meeting and learning from each other…. Our solutions are getting more powerful, and we want to get the word out… We want to...
by Truveta Staff | Nov 1, 2023 | News
October was a whirlwind month for Truveta, marked by participation in various conferences across the United States. In the span of less than 10 days, Truveta experts and customers presented at four different events, showcasing how Truveta Data is being used to enable...
by Truveta Staff | Oct 26, 2023 | Technology
Hidden under the surface of daily life, a disease often referred to as a “silent killer” is slowly taking hold over millions of Americans. While approximately 4.5M US adults have received a diagnosis of liver disease, a far larger yet largely unaware group is treading...
by Truveta Staff | Oct 2, 2023 | Technology
In the realm of medtech innovation, the margin for error is slim. Upwards of 90% of funding for an early-stage company may be allocated to engineering and clinical costs, making it essential for leaders to de-risk their clinical programs. Having access to a...
by Truveta Staff | Aug 22, 2023 | Technology
RSV season, which typically starts in fall and peaks in winter, could look very different this year. With newly approved vaccines for older adults and pregnant women and an immunization for infants poised to roll out, public health experts are optimistic about...
